Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
1. TM
WHOLESALE PRICE LIST
CASES ORDERED UNITS ORDERED CASES ORDERED UNITS ORDERED
DRINKS CASE
CASE
UNIT/ CREDIT
EACH PERSONAL CARE CASE
CASE
UNIT/ CREDIT
EACH
CREDIT CASE EACH CREDIT CASE EACH
034 Aloe Berry Nectar 1.080 142.44 12 .090 11.87 014 Aloe Bath Gelee .900 117.24 12 .075 9.77
077 Aloe Bits n’ Peaches 1.080 142.44 12 .090 11.87 067 Aloe Deodorant .900 115.50 30 .030 3.85
200 Aloe Blossum Tea .852 111.36 12 .071 9.28 260 Aloe-Jojoba Shampoo 1.065 139.20 15 .071 9.28
015 Aloe Vera Gel 1.080 142.44 12 .090 11.87 022 Aloe Lips 1.152 149.04 72 .016 2.07
002 Aloe Vera Juice 1.080 142.44 12 .090 11.87 038 Aloe Liquid Soap 1.062 138.06 18 .059 7.67
270 Forever Aloe2Go 1.820 239.80 4 .455 59.95 050 Aloe MPD .891 116.55 9 .099 12.95
196 Forever Freedom 1.632 215.40 12 .136 17.95 194 Aloe Styling Gel .795 104.55 15 .053 6.97
265 Forever Nat. Sp. Water .168 21.60 24 --- --- 030 Aloe Vet Formula .972 128.16 12 .081 10.68
262 Pomesteen Power 1.152 150.60 12 .096 12.55 261 Conditioning Rinse 1.065 139.20 15 .071 9.28
066 Forever Aloe Pro-Set 1.008 130.32 24 .042 5.43
CASES ORDERED UNITS ORDERED
NUTRITION CASE UNIT/ CREDIT
238 Forever Aloe Scrub 1.152 150.66 18 .064 8.37
CASE EACH
CREDIT CASE EACH
028 Forever Bright 1.224 157.68 36 .034 4.38
054 A-Beta-CarE 1.098 144.63 9 .122 16.07
070 Gentleman’s Pride 1.062 138.06 18 .059 7.67
048 Absorbent-C .852 111.36 12 .071 9.28
208 25th Edition-Women 1.110 146.82 6 .185 24.47
039 Arctic-Sea 1.152 150.93 9 .128 16.77
209 25th Edition-Men 1.110 146.82 6 .185 24.47
188 B-12 Plus 1.062 138.06 18 .059 7.67
068 Fields of Greens .954 125.46 18 .053 6.97 SONYA ALOE CASES ORDERED UNITS ORDERED
CASE UNIT/ CREDIT
264 Forever Active HA 1.632 215.40 12 .136 17.95 SKIN CARE LINE CREDIT
CASE
CASE EACH
EACH
222 Forever Act. Probiotic .726 95.76 6 .121 15.96 280 Aloe Balancing Creme 1.464 192.84 12 .122 16.07
206 Forever Calcium 1.044 138.00 12 .087 11.50 278 Aloe Exfoliator 1.152 150.84 12 .096 12.57
214 Forever Echinacea 1.020 134.04 12 .085 11.17 281 Aloe Nourish. Serum 1.908 251.64 12 .159 20.97
269 Forever Essentials 1.362 179.70 6 .227 29.95 277 Aloe Purify. Cleanser 1.536 201.24 12 .128 16.77
283 Forever Fizz 1.824 239.40 12 .152 19.95 279 Aloe Refresh. Toner 1.536 201.24 12 .128 16.77
198 Forever Kids .954 125.46 18 .053 6.97 282 Sonya Skin Care Kit 2.396 315.80 4 .599 78.95
215 Forever Multi-Maca 1.272 167.64 12 .106 13.97
CASES ORDERED UNITS ORDERED
235 Forever Vision 1.272 167.64 12 .106 13.97 SKIN CARE CASE
CASE
UNIT/ CREDIT
EACH
CREDIT CASE EACH
071 Garcinia Plus 1.161 152.82 9 .129 16.98
FACIAL
065 Garlic-Thyme .912 119.76 12 .076 9.98
233 Alluring Eyes 1.020 134.04 12 .085 11.17
047 Gin-Chia .912 119.76 12 .076 9.98
052 Aloe Activator 1.062 138.06 18 .059 7.67
073 Ginkgo Plus 1.098 144.63 9 .122 16.07
041 Aloe Fleur de Jouvence 1.227 161.61 3 .409 53.87
072 Lycium Plus 1.161 152.82 9 .129 16.98
187 Alpha-E Factor .936 122.96 8 .117 15.37
037 Nature-Min .912 119.76 12 .076 9.98
043 Exfoliating Cleanser .885 115.05 15 .059 7.67
271 Nature’s 18 1.140 149.70 6 .190 24.95
186 Eye Makeup Remover .774 100.26 18 .043 5.57
263 Pro 6 1.452 191.40 12 .121 15.95
044 Firming Foundation 1.104 144.96 12 .092 12.08
236 Forever Epiblanc .960 125.64 12 .080 10.47
CASES ORDERED UNITS ORDERED
234 Forever Marine Mask 1.620 213.48 18 .090 11.86
BEE PRODUCTS CASE
CASE
UNIT/ CREDIT
EACH
CREDIT CASE EACH
045 Mask Powder 1.008 132.36 12 .084 11.03
207 Bee Honey .960 125.55 15 .064 8.37 046 Night Creme 1.032 135.84 8 .129 16.98
026 Bee Pollen 1.170 153.72 18 .065 8.54 069 R3 Factor 1.032 135.84 8 .129 16.98
027 Bee Propolis 1.056 138.64 8 .132 17.33 042 Rehydrating Toner .885 115.05 15 .059 7.67
036 Royal Jelly 1.104 145.36 8 .138 18.17
BODY
CASES ORDERED UNITS ORDERED
056 Aloe Body Toner .936 122.96 8 .117 15.37
COMBO PAKS CASE
CASE
UNIT/ CREDIT
EACH 040 Aloe First 1.008 132.36 12 .084 11.03
CREDIT CASE EACH
001 TOF Combo 2.000 260.00 1 2.000 260.00 064 Aloe Heat Lotion 1.062 138.06 18 .059 7.67
075 TOF Mini Nutr. 1.000 130.00 1 1.000 130.00 062 Aloe Lotion 1.062 138.06 18 .059 7.67
076 TOF Mini Skin 1.000 130.00 1 1.000 130.00 205 Aloe MSM Gel .996 130.20 12 .083 10.85
9600 Sonya Showcase 2.000 260.00 1 2.000 260.00 051 Aloe Propolis Creme .996 130.20 12 .083 10.85
239 Aloe Sunless Tan 1.440 188.28 18 .080 10.46
061 Aloe Vera Gelly 1.062 138.06 18 .059 7.67
ALL PRICES ARE U.S. DOLLARS
www.foreverliving.com 057 Body Cond. Creme .876 115.50 6 .146 19.25
055 Body Toning Kit 1.050 138.51 3 .350 46.17
199 Forever Sunscreen 1.062 138.06 18 .059 7.67
063 Moisurizing Lotion 1.062 138.06 18 .059 7.67
2. WHOLESALE PRICE LIST
CASES ORDERED UNITS ORDERED
WEIGHT LOSS CASE
CREDIT
CASE
UNIT/
CASE
CREDIT
EACH
EACH
216 Clean 9 w Van - E .600 79.10 1 .600 79.10
217 Clean 9 w Van - S .600 79.10 1 .600 79.10
229 Clean 9 w Choc - E .600 79.10 1 .600 79.10
230 Clean 9 w Choc - S .600 79.10 1 .600 79.10
220 C+L Bus Pak w Van - E 2.000 260.00 1 2.000 260.00
221 C+L Bus w Van Pak - S 2.000 260.00 1 2.000 260.00
231 C+L Bus w Choc Pak-S 2.000 260.00 1 2.000 260.00
232 C+L Bus w Choc Pak-E 2.000 260.00 1 2.000 260.00
023 Fast Break Bar 1.344 168.00 96 .014 1.75
021 Forever Lite - Choc .936 122.96 8 .117 15.37
019 Forever Lite - Van .936 122.96 8 .117 15.37
237 Forever Lite Ultra Van 1.088 143.60 8 .136 17.95
266 Forever Lite Ultra Ch 1.088 143.60 8 .136 17.95
223 Lifestyle 30 w Gel - E 1.029 135.76 1 1.029 135.76
224 Lifestyle 30 w Gel - S 1.029 135.76 1 1.029 135.76
225 Lifestyle 30 w ABN - E 1.029 135.76 1 1.029 135.76
226 Lifestyle 30 w ABN - S 1.029 135.76 1 1.029 135.76
227 Lifestyle 30 w Peach - E 1.029 135.76 1 1.029 135.76
228 Lifestyle 30 w Peach - S 1.029 135.76 1 1.029 135.76
240 LS 30 Ultra Van w Gel - E 1.029 135.76 1 1.029 135.76
241 LS 30 Ultra Van w Gel - S 1.029 135.76 1 1.029 135.76
242 LS 30 Ultra Van w BN - E 1.029 135.76 1 1.029 135.76
243 LS 30 Ultra Van w BN - S 1.029 135.76 1 1.029 135.76
244 LS 30 Ultra Van w BP - E 1.029 135.76 1 1.029 135.76
245 LS 30 Ultra Van w BP - S 1.029 135.76 1 1.029 135.76
